| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | Not provided |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
LetopCS ® Chondroitin Sulfate Oligosaccharides are low molecular weight oligosaccharides with molecular weight not exceeding 1KDa obtained by enzymatic hydrolysis of chondroitin by unique strains of bacteria, certified by the U.S. FDA GARS, with a number of patents certified, and demonstrated in abundant preclinical trials, with higher bioavailability than chondroitin sulfate, and has a supplementary role in joint care, including lowering of inflammatory factors and reversal of joint injuries. It has a supporting role in reducing inflammatory factors, reversing joint damage and other joint care.
沪公网安备31010402001403号
